Les effets indésirables des neuroleptiques, 1990. ,
Guide du bon usage des psychotropes, 1997. ,
Utilisation thérapeutique psychiatrique d'une phénothiazine d'action centrale élective, 4560RP psychol, vol.110, pp.112-119, 1952. ,
« Les perturbations métaboliques liées à la prise d'antipsychotiques de seconde génération : revue de littérature et prise en charge ,
Preclinical pharmacology of neuroleptics: focus on new generation compounds, J Clin Psychiatry, vol.57, issue.suppl11, pp.4-11, 1996. ,
Focus on Quetiapine, Current Medical Research and Opinion, vol.15, issue.3, pp.145-51, 1999. ,
DOI : 10.1185/03007999909114085
A multicentre, double-blind, randomized comparison of quetiapine (ICI 204 ,
A comparison of quetiapine and chlorpromazine in the treatment of schizophrenia, Acta Psychiatrica Scandinavica, vol.45, issue.4, pp.265-73, 1997. ,
DOI : 10.1016/0149-2918(95)80102-2
Switch to quetiapine in antipsychotic agent-related hyperprolactinemia, Neurological Sciences, vol.23, issue.5, pp.233-238, 2002. ,
DOI : 10.1007/s100720200047
Are Weight Gain and Metabolic Side Effects of Atypical Antipsychotics Dose Dependent?, The Journal of Clinical Psychiatry, vol.70, issue.7, pp.1041-50, 2009. ,
DOI : 10.4088/JCP.08r04392
Quetiapine, CNS Drugs, vol.16, issue.4, pp.173-99, 2004. ,
DOI : 10.2165/00023210-200418030-00004
A multicentre, double-blind, randomized comparison of quetiapine (ICI 204 ,
A comparison of quetiapine and chlorpromazine in the treatment of schizophrenia, Acta Psychiatrica Scandinavica, vol.45, issue.4, pp.265-73, 1997. ,
DOI : 10.1016/0149-2918(95)80102-2
Switch to quetiapine in antipsychotic agent-related hyperprolactinemia, Neurological Sciences, vol.23, issue.5, pp.233-238, 2002. ,
DOI : 10.1007/s100720200047
Metabolic considerations in the use of antipsychotic medications: a review of recent evidence, J Clin Psychiatry, vol.68, issue.1, pp.20-27, 2007. ,
The Metabolic Effects of Antipsychotic Medications, The Canadian Journal of Psychiatry, vol.62, issue.8, pp.480-91, 2006. ,
DOI : 10.1176/appi.ajp.160.9.1651
Mechanism of Action of Atypical Antipsychotic Drugs and the Neurobiology of Schizophrenia, CNS Drugs, vol.181, issue.2, pp.389-409, 2006. ,
DOI : 10.2165/00023210-200620050-00004
Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values, J Pharmacol Exp Ther, vol.251, issue.1, pp.238-284, 1989. ,
Quetiapine, CNS Drugs, vol.16, issue.4, pp.173-99, 2004. ,
DOI : 10.2165/00023210-200418030-00004
Increasing D2 affinity results in the loss of clozapine??s atypical antipsychotic action, Neuroreport, vol.13, issue.6, pp.831-835, 2002. ,
DOI : 10.1097/00001756-200205070-00019
Classification des d??mences??: aspects nosologiques, M??decine Nucl??aire, vol.31, issue.6, pp.278-307, 2007. ,
DOI : 10.1016/j.mednuc.2007.04.005
Vascular dementia, Neurological Sciences, vol.27, issue.S1, pp.37-46, 2006. ,
DOI : 10.1007/s10072-006-0545-7
Alzheimer Disease as a Vascular Disorder: Nosological Evidence, Stroke, vol.33, issue.4 ,
DOI : 10.1161/01.STR.0000014421.15948.67
A systematic review of prevalence and incidence studies of dementia with Lewy bodies, Age and Ageing, vol.34, issue.6, pp.561-567, 2005. ,
DOI : 10.1093/ageing/afi190
Differences in neuropathologic characteristics across the Lewy body dementia spectrum, Neurology, vol.67, issue.11, pp.1931-1935, 2006. ,
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the Consortium on DLB International Workshop, Journal of Alzheimer's Disease, vol.9, issue.s3, pp.417-440, 2006. ,
DOI : 10.3233/JAD-2006-9S347
Neuropathology of dementia in Parkinson's disease: A prospective, community-based study, Annals of Neurology, vol.100, issue.5, pp.773-779, 2005. ,
DOI : 10.1002/ana.20635
Nosologie des d??mences. Le point de vue du neuropathologiste, Revue Neurologique, vol.162, issue.10, pp.921-929, 2006. ,
DOI : 10.1016/S0035-3787(06)75101-3
Soins infirmiers aux aînés en perte d'autonomie : une approche adaptée au CHSLD. Chapitre 2 Les démences, pp.15-20, 2006. ,
Predictors of Institutionalization Among Caregivers of Patients With Alzheimer's Disease, Journal of the American Geriatrics Society, vol.25, issue.7, pp.492-498, 1986. ,
DOI : 10.1111/j.1532-5415.1986.tb04239.x
Guide de prescription chez les personnes âgées ,
un programme d'éducation d es patients sous traitement anti-vitamine K sur les attitudes de prévention vis à vis, 2002. ,
Le bon usage des m??dicaments chez la personne ??g??e, La Revue de M??decine Interne, vol.25, issue.8, pp.582-90, 2004. ,
DOI : 10.1016/j.revmed.2004.02.027
Inappropriate medication use among hospitalized older adults in Italy: results from the Italian Group of Pharmacoepidemiology in the Elderly, European Journal of Clinical Pharmacology, vol.279, issue.2, pp.157-62, 2003. ,
DOI : 10.1001/jama.279.23.1877
Unnecessary drug use in frail older people at hospital discharge, J Am Geriatr Soc, vol.53, issue.9, pp.1518-1541, 2005. ,
Incidence and preventability of adverse drug events in nursing homes, The American Journal of Medicine, vol.109, issue.2, pp.87-94, 2000. ,
DOI : 10.1016/S0002-9343(00)00451-4
Updating the Beers Criteria for Potentially Inappropriate Medication Use in Older Adults, Archives of Internal Medicine, vol.163, issue.22, pp.2716-2740, 2003. ,
DOI : 10.1001/archinte.163.22.2716
Agreement Between Drugs-to-Avoid Criteria and Expert Assessments of Problematic Prescribing, Archives of Internal Medicine, vol.169, issue.14, pp.1326-1358, 2009. ,
DOI : 10.1001/archinternmed.2009.206
Defining inappropriate practices in prescribing for elderly people: a national consensus panel, CMAJ. Feb CMAJ. Feb, vol.1156156, issue.13, pp.385-91385, 1997. ,
Development and validation of an improving prescribing in the elderly tool, Can J Clin Pharmacol. Summer, vol.7, issue.2, pp.103-110, 2000. ,
Potentially inappropriate medications in the elderly: a French consensus panel list, European Journal of Clinical Pharmacology, vol.23, issue.8, pp.725-756, 2007. ,
DOI : 10.1007/s00228-007-0324-2
Conflicts and concordance between measures of medication prescribing quality. Med Care, pp.95-104, 2007. ,
Agreement Between Drugs-to-Avoid Criteria and Expert Assessments of Problematic Prescribing, Archives of Internal Medicine, vol.169, issue.14, pp.1326-1358, 2009. ,
DOI : 10.1001/archinternmed.2009.206
Assessing Care of Vulnerable Elders: Methods for Developing Quality Indicators, Ann Intern Med, vol.135, pp.647-652, 2001. ,
START: adaptation of a French language screening tool for detecting inappropriate prescriptions in older people, Can J Public Health, vol.100, issue.6, pp.426-457, 2009. ,
STOPP (Screening Tool of Older Person??s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation, Int. Journal of Clinical Pharmacology and Therapeutics, vol.46, issue.02, pp.72-83, 2008. ,
DOI : 10.5414/CPP46072
Modalités de prescription des médicaments aux personnes âgées ,
THE NOSOLOGY OF DEMENTIA, Neurologic Clinics, vol.18, issue.4, pp.773-88, 2000. ,
DOI : 10.1016/S0733-8619(05)70225-5
« Critères diagnostiques » American Psychiatric Association, 1996. ,
Principes d'évaluation de la pharmacothérapie en gériatrie : illustration à l'aide d'un cas de patient, pp.11-25, 2008. ,
Toll-like receptor 4 stimulation with the detoxified ligand monophosphoryl lipid A improves Alzheimer's disease-related pathology, Proc Natl Acad Sci, 2013. ,
Safety, tolerability, and antibody response of active A? immunotherapy with CAD106 in patients with ,
Association Francophone des Droits de l'Homme Agé (AFDHA) ? Alzheimer, l'éthique en question, p.44 ,
Prescription de neuroleptiques chez les patients déments : recommandations et réalités pratiques, 2010. ,